122 related articles for article (PubMed ID: 20406186)
1. Neuroprotection in amyotrophic lateral sclerosis: from pathology to treatment.
Murri L
CNS Neurol Disord Drug Targets; 2010 Jul; 9(3):258. PubMed ID: 20406186
[No Abstract] [Full Text] [Related]
2. Histone deacetylation and motor neuron degeneration.
Schmalbach S; Petri S
CNS Neurol Disord Drug Targets; 2010 Jul; 9(3):279-84. PubMed ID: 20406183
[TBL] [Abstract][Full Text] [Related]
3. Motor neuron trophic factors: therapeutic use in ALS?
Gould TW; Oppenheim RW
Brain Res Rev; 2011 Jun; 67(1-2):1-39. PubMed ID: 20971133
[TBL] [Abstract][Full Text] [Related]
4. A microfluidic approach to rescue ALS motor neuron degeneration using rapamycin.
Chennampally P; Sayed-Zahid A; Soundararajan P; Sharp J; Cox GA; Collins SD; Smith RL
Sci Rep; 2021 Sep; 11(1):18168. PubMed ID: 34518579
[TBL] [Abstract][Full Text] [Related]
5. Intrathecal delivery of hepatocyte growth factor from amyotrophic lateral sclerosis onset suppresses disease progression in rat amyotrophic lateral sclerosis model.
Ishigaki A; Aoki M; Nagai M; Warita H; Kato S; Kato M; Nakamura T; Funakoshi H; Itoyama Y
J Neuropathol Exp Neurol; 2007 Nov; 66(11):1037-44. PubMed ID: 17984685
[TBL] [Abstract][Full Text] [Related]
6. Cocaine use and abuse triggering sporadic young-onset amyotrophic lateral sclerosis.
Argyriou AA; Karanasios P; Makridou A; Vlachou M; Giannakopoulou F; Makris N
Neurodegener Dis; 2011; 8(3):146-8. PubMed ID: 20714119
[TBL] [Abstract][Full Text] [Related]
7. Quantifying motor neuron loss in ALS.
Narasimhan K
Nat Neurosci; 2006 Mar; 9(3):304. PubMed ID: 16498424
[No Abstract] [Full Text] [Related]
8. Loss of TDP-43 causes age-dependent progressive motor neuron degeneration.
Iguchi Y; Katsuno M; Niwa J; Takagi S; Ishigaki S; Ikenaka K; Kawai K; Watanabe H; Yamanaka K; Takahashi R; Misawa H; Sasaki S; Tanaka F; Sobue G
Brain; 2013 May; 136(Pt 5):1371-82. PubMed ID: 23449777
[TBL] [Abstract][Full Text] [Related]
9. No transneuronal degeneration between human cortical motor neurons and spinal motor neurons.
Terao S; Li M; Hashizume Y; Mitsuma T; Sobue G
J Neurol; 1999 Jan; 246(1):61-2. PubMed ID: 9987718
[No Abstract] [Full Text] [Related]
10. Guanabenz delays the onset of disease symptoms, extends lifespan, improves motor performance and attenuates motor neuron loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis.
Jiang HQ; Ren M; Jiang HZ; Wang J; Zhang J; Yin X; Wang SY; Qi Y; Wang XD; Feng HL
Neuroscience; 2014 Sep; 277():132-8. PubMed ID: 24699224
[TBL] [Abstract][Full Text] [Related]
11. Can neurotrophic factors prevent or reverse motoneuron injury in amyotrophic lateral sclerosis?
Appel SH; Smith RG
Exp Neurol; 1993 Nov; 124(1):100-2. PubMed ID: 8282067
[No Abstract] [Full Text] [Related]
12. Linking neuroinflammation to motor neuron degeneration in ALS: The critical role of CXCL13/CXCR5.
Arnoux A; Dupuis L
EBioMedicine; 2021 Jan; 63():103149. PubMed ID: 33278800
[No Abstract] [Full Text] [Related]
13. Amyotrophic lateral sclerosis from bench to bedside.
Lomen-Hoerth C
Semin Neurol; 2008 Apr; 28(2):205-11. PubMed ID: 18351522
[TBL] [Abstract][Full Text] [Related]
14. Spreading of motor neuron degeneration in ALS is not so random.
Corcia P; Couratier P
Rev Neurol (Paris); 2024 Jun; 180(6):475-476. PubMed ID: 38429156
[No Abstract] [Full Text] [Related]
15. Altered glutamatergic mechanisms and selective motor neuron degeneration in amyotrophic lateral sclerosis: possible role of glycine.
Plaitakis A
Adv Neurol; 1991; 56():319-26. PubMed ID: 1677233
[No Abstract] [Full Text] [Related]
16. GluR2 deficiency accelerates motor neuron degeneration in a mouse model of amyotrophic lateral sclerosis.
Van Damme P; Braeken D; Callewaert G; Robberecht W; Van Den Bosch L
J Neuropathol Exp Neurol; 2005 Jul; 64(7):605-12. PubMed ID: 16042312
[TBL] [Abstract][Full Text] [Related]
17. A systematic study of brainstem motor nuclei in a mouse model of ALS, the effects of lithium.
Ferrucci M; Spalloni A; Bartalucci A; Cantafora E; Fulceri F; Nutini M; Longone P; Paparelli A; Fornai F
Neurobiol Dis; 2010 Feb; 37(2):370-83. PubMed ID: 19874893
[TBL] [Abstract][Full Text] [Related]
18. Novel therapeutic targets in neurodegenerative diseases: lessons from amyotrophic lateral sclerosis.
Appel SH; Beers DR; Henkel JS; Zhao W
Curr Neurol Neurosci Rep; 2008 Sep; 8(5):353-5. PubMed ID: 18713569
[No Abstract] [Full Text] [Related]
19. Mitigating Motor Neuronal Loss in C. elegans Model of ALS8.
Zhang W; Colavita A; Ngsee JK
Sci Rep; 2017 Sep; 7(1):11582. PubMed ID: 28912432
[TBL] [Abstract][Full Text] [Related]
20. Kennedy's disease: a lower motor neuron model to identify upper motor neuron physiology in ALS.
Eisen A
Clin Neurophysiol; 2008 May; 119(5):971-2. PubMed ID: 18308629
[No Abstract] [Full Text] [Related]
[Next] [New Search]
